FDA Extends Holds in Immunotherapy Trials in Blood Cancers FDA Extends Holds in Immunotherapy Trials in Blood Cancers

The Food and Drug Administration has slowed or fully halted more trials of immunotherapies in multiple myeloma and other blood cancersMedscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news